EN-001
- Generic Name
- EN-001
Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- ENCell
- Target Recruit Count
- 12
- Registration Number
- NCT06328712
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- ENCell
- Target Recruit Count
- 88
- Registration Number
- NCT06328725
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
π°π·Samsung Medical Center, Seoul, Korea, Republic of
Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2024-08-30
- Lead Sponsor
- ENCell
- Target Recruit Count
- 7
- Registration Number
- NCT05338099
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A
- First Posted Date
- 2022-04-19
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- ENCell
- Target Recruit Count
- 9
- Registration Number
- NCT05333406
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath